These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29388189)

  • 21. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
    Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
    JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors.
    Schmidt SAJ; Vestergaard M; Baggesen LM; Pedersen L; Schønheyder HC; Sørensen HT
    Vaccine; 2017 Oct; 35(42):5589-5596. PubMed ID: 28874322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic literature review to assess the burden of herpes zoster disease in China.
    Yin D; Van Oorschot D; Jiang N; Marijam A; Saha D; Wu Z; Tang H; Diaz-Decaro J; Watson P; Xie X; Ren Y; He Y; Feng Y
    Expert Rev Anti Infect Ther; 2021 Feb; 19(2):165-179. PubMed ID: 32997550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults.
    McGirr A; Van Oorschot D; Widenmaier R; Stokes M; Ganz ML; Jung H; Varghese L; Curran D
    Appl Health Econ Health Policy; 2019 Oct; 17(5):723-732. PubMed ID: 31250218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake.
    Jain A; van Hoek AJ; Boccia D; Thomas SL
    Vaccine; 2017 Apr; 35(18):2315-2328. PubMed ID: 28343775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of risk factors for herpes zoster: population based case-control study.
    Forbes HJ; Bhaskaran K; Thomas SL; Smeeth L; Clayton T; Langan SM
    BMJ; 2014 May; 348():g2911. PubMed ID: 25134101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink.
    Lophatananon A; Carr M; Mcmillan B; Dobson C; Itzhaki R; Parisi R; Ashcroft DM; Muir KR
    BMC Public Health; 2023 Oct; 23(1):1903. PubMed ID: 37784088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
    Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
    Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
    Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Tseng HF; Smith N; Sy LS; Jacobsen SJ
    Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against zoster remains effective in older adults who later undergo chemotherapy.
    Tseng HF; Tartof S; Harpaz R; Luo Y; Sy LS; Hetcher RC; Jacobsen SJ
    Clin Infect Dis; 2014 Oct; 59(7):913-9. PubMed ID: 25097079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study.
    Martins D; McCormack D; Tadrous M; Gomes T; Kwong JC; Mamdani MM; Buchan SA; Antoniou T
    Clin Infect Dis; 2021 Jan; 72(2):279-284. PubMed ID: 31922540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.
    Sanford M; Keating GM
    Drugs Aging; 2010 Feb; 27(2):159-76. PubMed ID: 20104941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.
    Hawkins KL; Gordon KS; Levin MJ; Weinberg A; Battaglia C; Rodriguez-Barradas MC; Brown ST; Rimland D; Justice A; Tate J; Erlandson KM;
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):527-533. PubMed ID: 30179984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.
    Lin YH; Huang LM; Chang IS; Tsai FY; Lu CY; Shao PL; Chang LY; ;
    Vaccine; 2010 Feb; 28(5):1217-20. PubMed ID: 19944790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.
    Sato K; Adachi K; Nakamura H; Asano K; Watanabe A; Adachi R; Kiuchi M; Kobayashi K; Matsuki T; Kaise T; Gopala K; Holl K
    J Dermatol; 2017 Apr; 44(4):414-422. PubMed ID: 27917531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of social determinants in timely herpes zoster vaccination among older American adults.
    Shuvo S; Hagemann T; Hohmeier K; Chiu CY; Ramachandran S; Gatwood J
    Hum Vaccin Immunother; 2021 Jul; 17(7):2043-2049. PubMed ID: 33517829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends and disparity in zoster vaccine uptake in a managed care population.
    Hechter RC; Tartof SY; Jacobsen SJ; Smith N; Tseng HF
    Vaccine; 2013 Sep; 31(41):4564-8. PubMed ID: 23928461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.